We found that a truncated DAPK1 variant, containing the kinase domain, ankyrin repeats, and death domain (KD‐AR‐DD), retained potent tumor‐suppressive activity despite being approximately 50% shorter than the wild‐type protein. This evidence concerns the gene DAPK1 and neoplasm.